wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33400583-A4BCE7F2-A73E-461E-8B90-03BC83969740
Q33400583-A4BCE7F2-A73E-461E-8B90-03BC83969740
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400583-A4BCE7F2-A73E-461E-8B90-03BC83969740
Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma.
P2860
Q33400583-A4BCE7F2-A73E-461E-8B90-03BC83969740
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400583-A4BCE7F2-A73E-461E-8B90-03BC83969740
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0be55abb6e2cdd1115cf0d8e6e9431b6f6b8087b
P2860
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.